Efficacy and cardiovascular safety of DPP-4 inhibitors
3,5 In early T2DM managed with lifestyle alone, orforglipron lowered glycated hemoglobin A1c (HbA1c) by -1.24 to -1.48 percentage points over 40 weeks as compared to -0.41 with placebo, with no severe hypoglycemia reported and weight reduction ranging from 4.5% to 7.6%, 3 which led to mean HbA1c levels of 6.5-6.7%
No published study has given it subcutaneously or measured what fraction reaches circulation that way
PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides to identify your unique predispositionsincluding variants in FTO (rs9939609) and MC4R (rs17782313)all of which affect how your body tolerates medication and responds to dietary changes
95% confidence interval, 10.0 to 6.3 mmol mol 1 ), with a pronounced effect in those with SIDD
Careful dose adjustment is often needed